3.72
price down icon3.12%   -0.12
after-market Dopo l'orario di chiusura: 3.74 0.02 +0.54%
loading
Precedente Chiudi:
$3.84
Aprire:
$3.8151
Volume 24 ore:
21,171
Relative Volume:
0.41
Capitalizzazione di mercato:
$23.99M
Reddito:
$5.75M
Utile/perdita netta:
$-38.96M
Rapporto P/E:
-0.2983
EPS:
-12.47
Flusso di cassa netto:
$-32.63M
1 W Prestazione:
-7.92%
1M Prestazione:
-12.47%
6M Prestazione:
-45.75%
1 anno Prestazione:
-42.33%
Intervallo 1D:
Value
$3.61
$3.88
Intervallo di 1 settimana:
Value
$3.61
$4.16
Portata 52W:
Value
$2.92
$11.20

Kala Bio Inc Stock (KALA) Company Profile

Name
Nome
Kala Bio Inc
Name
Telefono
781-996-5252
Name
Indirizzo
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Name
Dipendente
38
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
KALA's Discussions on Twitter

Confronta KALA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
KALA
Kala Bio Inc
3.72 26.07M 5.75M -38.96M -32.63M -12.47
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Kala Bio Inc Stock (KALA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-03-30 Downgrade JP Morgan Neutral → Underweight
2021-08-06 Downgrade JP Morgan Overweight → Neutral
2020-09-14 Downgrade Jefferies Buy → Hold
2020-07-23 Iniziato Northland Capital Outperform
2020-06-01 Ripresa Oppenheimer Outperform
2020-05-27 Reiterato H.C. Wainwright Buy
2020-03-09 Aggiornamento BofA/Merrill Neutral → Buy
2019-12-17 Downgrade BofA/Merrill Buy → Neutral
2019-03-14 Iniziato Jefferies Buy
Mostra tutto

Kala Bio Inc Borsa (KALA) Ultime notizie

pulisher
May 29, 2025

KALA BIO to Present at Jefferies Global Healthcare Conference - The Manila Times

May 29, 2025
pulisher
May 29, 2025

KALA BIO to Reveal Latest Eye Disease Pipeline Progress at Major Jefferies Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 26, 2025

Q1 Earnings Estimate for KALA BIO Issued By HC Wainwright - Defense World

May 26, 2025
pulisher
May 25, 2025

HC Wainwright Lowers KALA BIO (NASDAQ:KALA) Price Target to $12.00 - Defense World

May 25, 2025
pulisher
May 24, 2025

Kala Bio stock target cut to $12 by H.C. Wainwright, retains buy - Investing.com Nigeria

May 24, 2025
pulisher
May 23, 2025

KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bi - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bio | KALA Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Price Target Reduced by H.C. Wainwright After Q3 Results | - GuruFocus

May 23, 2025
pulisher
May 23, 2025

KALA Price Target Reduced by H.C. Wainwright After Q3 Results | KALA Stock News - GuruFocus

May 23, 2025
pulisher
May 15, 2025

KALA BIO: Q1 Earnings Snapshot - New Haven Register

May 15, 2025
pulisher
May 14, 2025

Persistent Epithelial Defect Market on Track for Major - openPR.com

May 14, 2025
pulisher
May 14, 2025

KALA Focuses on Advancing KPI-012 Development Amid Pivotal Trials | KALA Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Kala Pharmaceuticals reports Q1 EPS ($1.41) vs ($4.20) last year - TipRanks

May 14, 2025
pulisher
May 14, 2025

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Algorhythm Holdings to Announce its Financial Results for the First Quarter 2025 - The Manila Times

May 14, 2025
pulisher
May 14, 2025

KALA's PCED Drug Could Reach 100,000 PatientsQ3 Trial Results Coming - Stock Titan

May 14, 2025
pulisher
May 12, 2025

Q2 EPS Forecast for Design Therapeutics Reduced by Analyst - Defense World

May 12, 2025
pulisher
May 12, 2025

Research Analysts Set Expectations for Datadog Q2 Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Issues Negative Estimate for Cadre Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

HC Wainwright Issues Positive Forecast for Clene Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

Equities Analysts Issue Forecasts for Cryoport Q2 Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Forecasts Lower Earnings for Denali Therapeutics - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 EPS Estimate for Cogent Biosciences Lifted by Analyst - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 EPS Estimates for Core Scientific Lifted by HC Wainwright - Defense World

May 12, 2025
pulisher
May 12, 2025

B. Riley Issues Negative Estimate for Fox Factory Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

KALA BIO (KALA) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 Earnings Forecast for Cryoport Issued By Leerink Partnrs - Defense World

May 12, 2025
pulisher
May 11, 2025

KALA BIO (KALA) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

Fluence Energy, Inc. (NASDAQ:FLNC) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 08, 2025
pulisher
May 07, 2025

Dimensional Fund Advisors LP Sells 5,772 Shares of Turning Point Brands, Inc. (NYSE:TPB) - Defense World

May 07, 2025
pulisher
May 04, 2025

Head-To-Head Survey: Equillium (NASDAQ:EQ) and KALA BIO (NASDAQ:KALA) - Defense World

May 04, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Has $426,000 Stake in Sidus Space, Inc. (NASDAQ:SIDU) - Defense World

May 03, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Increases Position in Forte Biosciences, Inc. (NASDAQ:FBRX) - Defense World

May 03, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Boosts Holdings in KALA BIO, Inc. (NASDAQ:KALA) - Defense World

May 03, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Has $403,000 Stake in Mobix Labs, Inc. (NASDAQ:MOBX) - Defense World

May 03, 2025
pulisher
Apr 30, 2025

Wix.com Ltd [WIX] Insider Activity: An Update for Investors - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Understanding the Risks of Investing in CureVac N.V (CVAC) - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Recent Insider Activity Could Benefit Insperity Inc (NSP) - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Analyzing Kala Bio Inc (KALA) After Recent Trading Activity - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

International Business Machines Corp [IBM] Stock sold by Insider Thomas Robert David for $6.72 million - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Aurora Cannabis Inc [ACB] Investment Guide: What You Need to Know - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Insider Sale Alert: Angi Inc [ANGI] – Is it Time to sell? - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Kala Bio Inc (KALA) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com

Apr 30, 2025
pulisher
Apr 30, 2025

Kala Bio Inc (KALA) Stock: A Year of Market Fluctuations - investchronicle.com

Apr 30, 2025
pulisher
Apr 30, 2025

Piper Sandler gives a Neutral recommendation for RxSight Inc (RXST) - knoxdaily.com

Apr 30, 2025
pulisher
Apr 14, 2025

Oppenheimer maintains Kala Bio stock Outperform with $15 target By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 11, 2025

Kala Bio announces executive retention bonuses - Investing.com Australia

Apr 11, 2025
pulisher
Apr 11, 2025

KALA stock touches 52-week low at $3.4 amid market challenges By Investing.com - Investing.com South Africa

Apr 11, 2025
pulisher
Apr 11, 2025

Kala Bio announces executive retention bonuses By Investing.com - Investing.com South Africa

Apr 11, 2025
pulisher
Apr 11, 2025

Kala Pharmaceuticals Announces Executive Retention Agreements - TipRanks

Apr 11, 2025
pulisher
Apr 11, 2025

KALA stock touches 52-week low at $3.4 amid market challenges - Investing.com

Apr 11, 2025

Kala Bio Inc Azioni (KALA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Capitalizzazione:     |  Volume (24 ore):